Actualités Zyus Life Sciences Corporation - ZYUS | Actions TSX Venture Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Zyus Life Sciences Corporation (ZYUS)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ZYUS Actualités

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Zyus Life Sciences Corporation (ZYUS) Actualités

Zyus Life Sciences Corporation (ZYUS)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ZYUS Actualités

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application